Casey Ross

4 days ago | statnews.com | Casey Ross |Bob Herman |Lizzy Lawrence |Tara Bannow

For most of its 18-year history, Semler Scientific marketed a single medical product that became a popular way for top Medicare insurers like UnitedHealth Group to detect artery blockages in older Americans. But in its most recent earnings call, the device maker’s focus on artery health gave way to a different strategy: “We are a bitcoin-first company,” Eric Semler, the company’s chairman, declared in announcing a large purchase of the cryptocurrency.

3 weeks ago | statnews.com | Casey Ross |Tara Bannow |Bob Herman

An internal document drafted in advance of UnitedHealth Group’s shareholder meeting this week reveals how the company’s leadership — facing an extraordinary series of financial and legal challenges — sought to downplay complaints about its business practices and assure jittery investors that it will soon return to maximum profitability.

1 month ago | statnews.com | Matthew Herper |Casey Ross

The American Society of Clinical Oncology, the largest professional organization in cancer care, announced Wednesday that it had partnered with Google Cloud to develop an AI-based tool to help physicians rapidly question the organization’s guidelines on best practices in diagnosing and treating cancer.

1 month ago | statnews.com | Casey Ross |Jonathan Wosen

She is serving an 11-year prison sentence for misleading investors and is barred from participating in federal health programs for 90 years. But Elizabeth Holmes’ dream of a diagnostic testing revolution is once again the talk of health care. The emergence of Haemanthus, a company formed by Holmes’ partner, Billy Evans, triggered a mix of shock, anger, and rueful skepticism on Monday, as one of health care’s most infamous frauds morphed into a new form, with fresh capital behind it.

1 month ago | statnews.com | Katie M. Palmer |Casey Ross

The Food and Drug Administration said it will rapidly roll out a generative artificial intelligence model to assist scientific reviews across the agency, setting up a high-stakes test of the technology’s use in vetting products used in the care of millions of Americans.